{
  "main_header": {
    "sid": 1003095,
    "name": "Deccan Healthcar",
    "stock_name": "Deccan Healthcar",
    "full_name": "Deccan Health Care Ltd",
    "name_url": "stocks-analysis/deccan-healthcar",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "19.39",
    "chg": 0.84,
    "chgp": "4.53%",
    "dir": 1,
    "prev_price": "18.55",
    "mcapval": "43.95 Cr",
    "mcap": "Micro Cap",
    "scripcode": 542248,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE452W01019",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:19 AM",
    "bse_nse_vol": 21711,
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/deccan-healthcar-1003095-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Deccan Health Care Adjusts Valuation Amid Mixed Industry Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-cares-valuation-grade-upgraded-from-fair-to-attractive-amid-stock-decline-9-1656103",
        "imagepath": "",
        "date": "2025-04-01 08:00:46",
        "description": "Deccan Health Care, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's current price stands at 16.94, reflecting a notable decline from its previous close of 18.07. Over the past year, Deccan Health Care has experienced a stock return of -38.67%, contrasting sharply with a 5.11% return from the Sensex.\n\nKey financial metrics reveal a PE ratio of 33.10 and an EV to EBITDA ratio of 11.67, indicating a competitive position within its industry. The PEG ratio is notably low at 0.22, suggesting potential for growth relative to its earnings. However, the company's return on capital employed (ROCE) and return on equity (ROE) are relatively modest at 2.41% and 1.56%, respectively.\n\nWhen compared to its peers, Deccan Health Care's valuation metrics present a mixed picture. While it holds an attractive valuation, competitors like Shukra Pharma and Shre..."
      },
      {
        "title": "Deccan Health Care Ltd Experiences Surge Amidst Broader Market Stability and Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-ltd-surges-18-36-today-reaching-intraday-high-of-rs-19-53-1548697",
        "imagepath": "",
        "date": "2025-03-21 11:45:13",
        "description": "Deccan Health Care Ltd is witnessing significant buying activity today, with the stock surging by 18.36%. This performance starkly contrasts with the Sensex, which has only gained 0.61% during the same period. Despite this strong one-day performance, Deccan Health Care's performance over the past week shows a slight decline of 0.41%, while the Sensex has risen by 4.04%. \n\nIn the context of longer-term trends, Deccan Health Care has faced challenges, with a 34.20% drop over the past year compared to the Sensex's gain of 5.74%. The stock's volatility today has been notable, with an intraday high of Rs 19.53 and a volatility rate of 7.84%. \n\nThe stock's current price is above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed performance in the short to medium term. The strong buying pressure today may be attributed to various factors, includin..."
      },
      {
        "title": "Deccan Health Care Faces Significant Stock Volatility Amidst Declining Performance Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-stock-hits-52-week-low-amid-significant-decline-and-weak-fundamentals-1510260",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DeccanHealthCar_priceRelatedfactors_745548.png",
        "date": "2025-03-20 15:36:56",
        "description": "Deccan Health Care, a microcap in the Pharmaceuticals sector, hit a new 52-week low today after significant volatility. The company has seen a 41.30% decline in stock price over the past year, with concerning fundamentals and flat quarterly results, despite a slight increase in promoter confidence."
      },
      {
        "title": "Deccan Health Care Stock Hits All-Time Low Amidst Ongoing Financial Struggles",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-stock-hits-all-time-low-at-rs-16-25-amid-significant-decline-1509440",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DeccanHealthCar_priceRelatedfactors_743796.png",
        "date": "2025-03-20 15:12:00",
        "description": "Deccan Health Care, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, recently hitting an all-time low. The company reported a steep decline in stock performance and operating profits, alongside disappointing quarterly results, while promoter confidence has slightly increased amid ongoing challenges."
      },
      {
        "title": "Deccan Health Care Adjusts Valuation Amid Mixed Market Positioning and Peer Comparison",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-cares-valuation-grade-upgraded-from-fair-to-attractive-amid-stock-decline-1462633",
        "imagepath": "",
        "date": "2025-03-19 08:01:00",
        "description": "Deccan Health Care, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's financial metrics reveal a PE ratio of 33.41 and an EV to EBITDA ratio of 11.79, indicating its current market positioning. The PEG ratio stands at 0.23, suggesting a favorable growth outlook relative to its earnings.\n\nIn comparison to its peers, Deccan Health Care's valuation metrics present a mixed picture. For instance, while it maintains a higher PE ratio than some competitors like Kopran, which has a PE of 17.26, it is lower than Shree Ganesh Remedies, which is noted for its expensive valuation. Additionally, Deccan's EV to Sales ratio of 0.54 is competitive, especially when compared to peers like Bharat Parenterals, which is categorized as risky.\n\nDespite recent stock performance showing a decline over various periods, including a 41.54% drop year-to-date, the compa..."
      },
      {
        "title": "Deccan Health Care Faces Ongoing Challenges Amid Significant Stock Volatility and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-hits-52-week-low-amid-continued-stock-decline-and-poor-performance-1426229",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DeccanHealthCar_priceRelatedfactors_685331.png",
        "date": "2025-03-18 09:59:52",
        "description": "Deccan Health Care has faced significant volatility, reaching a new 52-week low and underperforming its sector. The stock has declined over the past week and year, with troubling financial metrics, including a low return on equity and a decrease in operating profits. Promoter confidence has slightly increased amid ongoing challenges."
      },
      {
        "title": "Deccan Health Care Faces Significant Stock Volatility Amid Weak Fundamentals and Promoter Confidence Rise",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-hits-52-week-low-amid-continued-stock-decline-and-poor-performance-2-1498514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DeccanHealthCar_priceRelatedfactors_685328.png",
        "date": "2025-03-18 09:59:51",
        "description": "Deccan Health Care, a microcap in the Pharmaceuticals & Drugs sector, has faced significant stock volatility, hitting a new 52-week low. The company has underperformed its sector and recorded a substantial decline over the past year, with weak long-term fundamentals. However, promoter confidence has increased recently."
      },
      {
        "title": "Deccan Health Care Faces Significant Stock Volatility Amid Weak Financial Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-hits-52-week-low-amid-continued-stock-decline-and-poor-performance-3-1498515",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DeccanHealthCar_priceRelatedfactors_685327.png",
        "date": "2025-03-18 09:59:47",
        "description": "Deccan Health Care has faced significant volatility, reaching a new 52-week low and underperforming its sector. The stock has declined over the past week and year, with weak long-term fundamentals. However, promoter confidence has increased, as evidenced by a rise in their stake in the company."
      },
      {
        "title": "Deccan Health Care Faces Significant Volatility Amid Broader Market Gains and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/deccan-health-care-hits-52-week-low-amid-continued-stock-decline-and-weak-fundamentals-2-1426234",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/DeccanHealthCar_priceRelatedfactors_685330.png",
        "date": "2025-03-18 09:59:47",
        "description": "Deccan Health Care, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility and a seven-day decline. The company shows weak long-term fundamentals, including negative growth in operating profits and low return on equity, despite increased promoter confidence in recent holdings."
      }
    ],
    "total": 28,
    "sid": "1003095",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/deccan-health-care-1003095"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Allotment Of Equity Shares",
      "datetime": "08-Apr-2025",
      "details": "Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/04/2025 inter alia to consider and approve 1. The allotment of Equity Shares pursuant to conversion of Convertible Warrants to Focal Ventures Private Limited Warrant holder of the Company (Person Other than the Promoter/Promoter Group). 2. To consider and discuss any other business with the permission of the chairman",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "01-Apr-2025",
      "details": "1. Considered and Approved Conversion of warrants into equity shares of the Company 2. Other Matter with Permission of the Chairman",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Deccan Health Care Adjusts Valuation Amid Mixed Industry Performance Metrics

2025-04-01 08:00:46

Deccan Health Care, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's current price stands at 16.94, reflecting a notable decline from its previous close of 18.07. Over the past year, Deccan Health Care has experienced a stock return of -38.67%, contrasting sharply with a 5.11% return from the Sensex. Key financial metrics reveal a PE ratio of 33.10 and an EV to EBITDA ratio of 11.67, indicating a competitive position within its industry. The PEG ratio is notably low at 0.22, suggesting potential for growth relative to its earnings. However, the company's return on capital employed (ROCE) and return on equity (ROE) are relatively modest at 2.41% and 1.56%, respectively. When compared to its peers, Deccan Health Care's valuation metrics present a mixed picture. While it holds an attractive valuation, competitors like Shukra Pharma and Shre...

Read More

Deccan Health Care Ltd Experiences Surge Amidst Broader Market Stability and Volatility

2025-03-21 11:45:13

Deccan Health Care Ltd is witnessing significant buying activity today, with the stock surging by 18.36%. This performance starkly contrasts with the Sensex, which has only gained 0.61% during the same period. Despite this strong one-day performance, Deccan Health Care's performance over the past week shows a slight decline of 0.41%, while the Sensex has risen by 4.04%. In the context of longer-term trends, Deccan Health Care has faced challenges, with a 34.20% drop over the past year compared to the Sensex's gain of 5.74%. The stock's volatility today has been notable, with an intraday high of Rs 19.53 and a volatility rate of 7.84%. The stock's current price is above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating mixed performance in the short to medium term. The strong buying pressure today may be attributed to various factors, includin...

Read More

Deccan Health Care Faces Significant Stock Volatility Amidst Declining Performance Trends

2025-03-20 15:36:56

Deccan Health Care, a microcap in the Pharmaceuticals sector, hit a new 52-week low today after significant volatility. The company has seen a 41.30% decline in stock price over the past year, with concerning fundamentals and flat quarterly results, despite a slight increase in promoter confidence.

Read More

Deccan Health Care Stock Hits All-Time Low Amidst Ongoing Financial Struggles

2025-03-20 15:12:00

Deccan Health Care, a microcap in the Pharmaceuticals & Drugs sector, has faced significant volatility, recently hitting an all-time low. The company reported a steep decline in stock performance and operating profits, alongside disappointing quarterly results, while promoter confidence has slightly increased amid ongoing challenges.

Read More

Deccan Health Care Adjusts Valuation Amid Mixed Market Positioning and Peer Comparison

2025-03-19 08:01:00

Deccan Health Care, a microcap player in the Pharmaceuticals & Drugs sector, has recently undergone a valuation adjustment. The company's financial metrics reveal a PE ratio of 33.41 and an EV to EBITDA ratio of 11.79, indicating its current market positioning. The PEG ratio stands at 0.23, suggesting a favorable growth outlook relative to its earnings. In comparison to its peers, Deccan Health Care's valuation metrics present a mixed picture. For instance, while it maintains a higher PE ratio than some competitors like Kopran, which has a PE of 17.26, it is lower than Shree Ganesh Remedies, which is noted for its expensive valuation. Additionally, Deccan's EV to Sales ratio of 0.54 is competitive, especially when compared to peers like Bharat Parenterals, which is categorized as risky. Despite recent stock performance showing a decline over various periods, including a 41.54% drop year-to-date, the compa...

Read More

Deccan Health Care Faces Ongoing Challenges Amid Significant Stock Volatility and Decline

2025-03-18 09:59:52

Deccan Health Care has faced significant volatility, reaching a new 52-week low and underperforming its sector. The stock has declined over the past week and year, with troubling financial metrics, including a low return on equity and a decrease in operating profits. Promoter confidence has slightly increased amid ongoing challenges.

Read More

Deccan Health Care Faces Significant Stock Volatility Amid Weak Fundamentals and Promoter Confidence Rise

2025-03-18 09:59:51

Deccan Health Care, a microcap in the Pharmaceuticals & Drugs sector, has faced significant stock volatility, hitting a new 52-week low. The company has underperformed its sector and recorded a substantial decline over the past year, with weak long-term fundamentals. However, promoter confidence has increased recently.

Read More

Deccan Health Care Faces Significant Stock Volatility Amid Weak Financial Fundamentals

2025-03-18 09:59:47

Deccan Health Care has faced significant volatility, reaching a new 52-week low and underperforming its sector. The stock has declined over the past week and year, with weak long-term fundamentals. However, promoter confidence has increased, as evidenced by a rise in their stake in the company.

Read More

Deccan Health Care Faces Significant Volatility Amid Broader Market Gains and Weak Fundamentals

2025-03-18 09:59:47

Deccan Health Care, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility and a seven-day decline. The company shows weak long-term fundamentals, including negative growth in operating profits and low return on equity, despite increased promoter confidence in recent holdings.

Read More

View All News